LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Outlook Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKEROTLK
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / OTLK COVERAGE

What’s moving Outlook Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Outlook Therapeutics, Inc. Announces Presentation by Lawrence A. Kenyon at Webull Corporate Connect Webinar on January 29, 2025

Outlook Therapeutics, Inc. Announces Presentation by Lawrence A. Kenyon at Webull Corporate Connect Webinar on January 29, 2025

The story matters when it changes Outlook Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest OTLK filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2026-02-17 · Period 2025-12-31SEC ↗10-KAnnual financial reportFiled 2025-12-19 · Period 2025-09-30SEC ↗8-KMaterial company eventFiled 2026-07-24 · Period 2026-07-24SEC ↗8-KMaterial company eventFiled 2026-07-24 · Period 2026-07-21SEC ↗8-KMaterial company eventFiled 2026-07-16 · Period 2026-07-16SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-06-01 · Period 2026-07-16SEC ↗4Official SEC filingFiled 2026-07-29 · Period 2026-07-29SEC ↗
EARNINGS / QUARTERLY TRACKER

Outlook Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.